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1. Introduction 
Until a few years ago, the small bowel was an organ which was very difficult to explore 
with the available endoscopic, radiological and nuclear medicine techniques due to 
anatomical (i.e. distance from external orifices, length) and physiological (i.e. active 
peristalsis) reasons. In routine practice, only the last few centimeters of the ileum was 
accessible to retrograde visualization by ileo-colonoscopy. Exploration from the proximal 
side by push, sonde or intra-operative enteroscopy were invasive procedures that did not 
always allow us to visualize the lesions in the small bowel (Galmi che et al.,2008). Sonde 
enteroscopy had been abandoned in the 90’s because it was a tedious technique (long 
duration of the procedure) and it had several technical limitations. Push enteroscopy is 
limited by the depth of insertion of the scope and is poorly tolerated. Intra-operative 
enteroscopy is the most effective of these techniques, but it is the most invasive with a 
significant percentage of adverse side effects (Rondonotti  et al., 2007). 
The concept for small bowel capsule was developed independently by two groups. Dr. Paul 
Swain, a British gastroenterologist demonstrated the first live transmissions in 1996 with the 
broadcast of a pig's stomach. In 1997, he collaborated with Dr. Gavriel  Iddan, a mechanical 
engineer working with the Israel Ministry of Defense(Appleyard et al.,2001;Meron,2000;Swain 
et al.,1996). Successful animal trials were conducted and first published in 2000. (Swain et 
al.,1996) Human studies followed and the use of capsule endoscopy (CE) in clinical trials was 
first published in 2001. (Kornbluth et al.,2004)  Since the emergence of CE, more than 1000000 
capsules have been swallowed worldwide and nearly 1000 peer reviewed publications have 
appeared in the literature. This article reviews the fundamental of wireless capsule endoscopy. 
Special attention is paid to the indications, benefits and drawbacks of the technique, as well as 
to the strengths and limitations of clinical data available to the date. 
2. Technical features of the capsule 
The M2A capsule (figure-1) initially, and Pillcam SB2 (Small Bowel) later, from GIVEN 
(Gastro Intestinal Video Endoscopy, Given Imaging Limited, Yoqneam, Israel), and endo 
capsule from Olympus are the capsules that have been approved for use in the clinical 
setting, approved in Europe by the European Medicines Agency and in the United States by 
the Food and Drug Administration in 2001 (Pannazio, 2006). The capsule which measures 
only 11 mm × 26 mm and weighs 3.7 g, holds a metal oxide semiconductor imaging chip 
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video camera, 6 white light-emitting diode illumination sources, 2 silver-oxide batteries and 
a radio telemetry transmitter. The image filed is 140 degrees, magnification is × 8 and the 
depth of view is 1 to 30 mm (Iddan et al.,2000;Davis et al.,2005).  
 
 
Fig. 1. M2A Capsule 
Once swallowed, the capsule moves thorough the intestine via peristalsis and is excreted in 
the stool. The camera takes two images per second as it sweeps the intestine and transmits 
these to eight lead sensor arrays, arranged in a specific manner and taped to the anterior 
abdominal wall, connected to a recording device in the belt for the duration of the battery 
life, which is 6-8 h. Once the study is completed, the recording device and sensor arrays are 
removed and the images (50000-60000 images total) are downloaded to a computer with 
reporting and processing of images and data (Rapid, Given Imaging) software that displays 
the video images on a computer monitor. This software includes a localizing system, blood 
detector and some features to assist the interpreter. The suspected blood indicator is quite 
good at detecting active bleeding, but is not so useful at detecting other lesions and does not 
replace careful examination of the CE. It is recommended that patients avoid magnetic fields 
such as magnetic resonance imaging (MRI), and metal detectors until the capsule is excreted 
in the stool, which usually occurs in 24-48 h. Small bowel preparation is still a controversial 
issue. Some groups used fasting or clear liquids for 10 to 12 h (or even for 24 h) before the 
study, although some studies suggest that bowel preparation (with 2 or 4 liters of 
polyethylene glycol based electrolyte solution or oral sodium phosphate preparation) 
improves the visualization of the small intestine(Dai et al.,2005;de Franchis et al.,2005).A 
recent Spanish prospective multicenter trial published in abstract form, has shown that all 
three strategies have similar results(Pons et al.,2006). After ingestion of the capsule, patients 
were allowed to drink clear liquids after 2 h and eat a light meal after 4 h and were observed 
for 8 h at the study site. 
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3. Indication 
Capsule endoscopy is mainly indicated (Table-1) for the evaluation of Small Bowel (SB) 
diseases, particularly for the diagnosis of Obscure Gastro Intestinal Bleeding (OGIB). CE can 
be used in a variety of conditions including Crohn’s disease (CD), mal-absorption, chronic 
diarrhea, evaluation of refractory iron   deficiency anemia,    abdominal   pain,   polyposis 
syndromes, celiac disease, and detection of SB tumors. 
 
Small Bowel 
 Obscure gastrointestinal bleeding 
 Occult (positive FOBT) 
 Evaluation of iron deficiency anemia 
 Crohn’s disease 
 Suspected crohn’s disease 
 Indeterminate colitis 
 Assessment of mucosal healing 
 Abdominal pain 
 Craft-versus-host disease 
 Surveillance of polyposis syndromes 
 Celiac disease 
 Suspected small bowel tumors 
 Follow up of small intestine Transplantation 
 Evaluation of abnormal SB Imaging 
 Evaluation of drug induced injury 
Esophagus 
 Barrett’s esophagus 
 Esophagitis 
 Variceal evaluation 
Table 1. Indication 
Graft versus host disease (GVHD) and follow up of small intestine transplantation are rare 
indications. In later years, breakthrough developments in CE technology have enabled the 
direct visualization of the upper (de Franchis et al.,2008;Fernandez et al.,2007)and lower 
segments (Deviere et al.,2008;Schoof et al.,2006)of the gut using specifically designed capsules. 
CE with high frame rate (PillCam Eso, Given Imaging)  can be used  for esophageal disorders, 
such as non-invasive   evaluation   of   esophageal varices, esophagitis and Barrett’s esophagus 
(Galmiche et al.,2008). Colon capsule endoscopy is an emerging form of colon imaging that 
may be useful to improve compliance with colorectal cancer screening. 
3.1 Obscure GI bleeding 
Obscure GI bleeding (OGIB) is the most common indication for CE examination. CE has a 
high diagnostic yield in OGIB, facilitates effective decision-making regarding subsequent 
investigations and treatments (Eliakim et al., 2008).Diagnostic yield of CE for OGIB varied 
between 31% and 91% (Adler et al.,2004;Costamagna et al.,2004;Ell et al.,2002;Ersoy et 
al.,2006;Ge et al.,2004;Golder et al.,2006;Hartmann et al 2003,2005;Lewis & Swain,2002;Mata 
et al.,2004;Panazio et al.,2004;Scapa et al.,2002;Saurin et al.,2003;Saperas et al.,2007;Van 
gossum et al.,2003;Voderholzer et al.,2003). The published studies of CE for OGIB were 
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reviewed and reported that sensitivity ranged from 79% to 95% and specificity from 75% to 
100%(Varela Lema & Ruano-Ravina, 2008 ). The positive predictive value (PPV) varied from 
94% to 100% and the negative predictive value (NPV) from 80% to 100%.   
 
   
 
    
Fig. 2. VCE images of lesions found in patients with obscure-overt GI bleeding. A: Multiple 
angiodysplasias in the jejunum; B: A jejunal mass with active bleeding; C: An ileal ulcer in a 
patient with newly diagnosed Crohn’s disease. D: Benign lymphoid hyperplasia located 
diffusely through the GI tract in a patient with CVID; E: A jejunal polyp in a patient with 
peutz-jeghers disease; F: Multiple small polyps in the ileum. 
Capsule endoscopy led to a change in therapeutic management in 9%-77% of patients. A 
recent study (Albert et al., 2008) reported that CE detected the bleeding source in 76.8% of 
patients. The diagnostic yield of CE in OGIB depends on the type of bleeding. Highest yield 
of CE was 92.3% in patients with active bleeding (Pannazio et al., 2004) compared to those 
with obscure occult bleeding (44.2%). Researchers observed a reverse relationship between 
findings and time after last bleeding episode. The longer the time from last bleed, the lower 
the diagnostic yield. Do the lesions discovered by CE have any bleeding potential or clinical 
importance in terms of management change? Saurin et al., 2003 showed that CE detects 
more lesions, but only half of them have true bleeding potential. CE is superior to other 
techniques in diagnosing the source of bleeding. The yield for CE is 63% and 67% compared 
with 28% for push enteroscopy (PE) and 8% for barium study(Lewis,2008). 
3.2 Crohn’s disease 
Crohn’s disease (CD) is a chronic inflammatory disease that can involve any part of the 
Gastro-intestinal (GI) system, and disease is confined to the SB in about one-third of the 
patients. There is no single test to diagnose CD completely, so CD diagnosis can be established 
with a combination of clinical, endoscopic and histological findings. Most imaging studies lack 
sensitivity to identify early changes, and endoscopy does not allow total examination of the 
bowel. CE is able to identify mucosal changes before other technologies. It has a valuable role 
in the evaluation of the SB in patients with suspected or known CD. The use of CE in the 
A B C
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diagnosis of small bowel CD(Papadakis et al.,2005) has been examined in several studies and 
found to be superior to small bowel follow-through(Fireman et al .,2003;Herrerias et al., 
2003;Mow et al.,2004), enteroclysis (chong et al.,2005;Liangpunsakul et al.,2003), push 
enteroscopy(chong et al.,2005) and CT enteroclysis (Voderholzer et al.,2005) for identifying 
small intestinal disease. the Diagnostic yield of CE was  compared with other modalities in 
patients with suspected small bowel CD, yield of CE was 63% compared with 23% for barium 
radiography. When compared with ileo-colonoscopy, CE had a higher yield (61% vs 46%). 
Compared with PE, CE had a 38% higher yield, and when compared with CT enterography, 
the yield of CE was 69% vs 30%. Due to its high diagnostic yield, CE will have a very 
important place in the diagnostic workup of patients with CD, but more studies are needed to 
make such suggestions since there was no statistical significance in the incremental yield 
between CE and other diagnostic modalities in patients suspected of having CD in an meta 
analysis (Triester et al., 2006). However, there was a significant difference in yield of CE over 
alternative methods in patients with known CD, who were being evaluated for SB recurrence 
(Triester et al., 2006) Yield of CE is low when performed in patients with abdominal pain 
alone; when other criteria are added, this yield is increased (Lewis, 2008).Capsule endoscopy 
can be used for the assessment of mucosal healing after treatment.  
The only limitation of CE is its inability to offer biopsy for histological examination.  
A scoring system has been proposed to evaluate CD on the basis of CE findings of villous 
structure, ulceration and stenosis. Each variable is assessed by size and extent of the change 
(Grelnek et al., 2008). However, further studies are needed to clarify the helpfulness of this 
system. The score provides a common language to quantify mucosal changes associated 
with any inflammatory process. The index does not diagnose or measure a disease, it 
measures mucosal change. In addition, this scoring index does not have the discriminatory 
ability to differentiate between illnesses. This index could be helpful in determining mucosal 
healing after therapy in CD (Lewis, 2008). Mucosal breaks and aphthous ulcers or erosions 
are also seen in asymptomatic healthy volunteers. Since non-steroidal anti-inflammatory 
drugs (NSAIDs) may cause ulcerations resembling those of CD, patients should be advised 
to stop such drugs at least one month before the CE examination (Mergener et al., 2007). It is 
difficult to differentiate these findings with the presence of CD.  
3.3 Celiac disease 
Celiac disease is an immune-mediated disease characterized by chronic SB inflammation that 
may result in mucosal atrophy, mal-absorption and related clinical manifestations. Diagnosis 
is based on the combination of serologic, endoscopic and typical histological changes of the SB 
biopsy in clinically suspected patients. Its prevalence is around 1% in the United States. There 
are four endoscopic changes suggestive of villous atrophy: loss of mucosal folds, mosaic 
mucosal pattern, scalloping of the duodenal folds and nodularity of the mucosa (Spada et al., 
2008). It is no surprise that CE provides high resolution images that contain such changes. 
Fourty three patients with signs or symptoms suggestive of celiac disease and positive 
serological markers were evaluated (Rondonotti et al., 2007). Patients underwent both CE and 
upper GI endoscopy. Characteristic histological changes were observed in 32 patients. Using 
this as a gold standard, 87.5% of patients were diagnosed by CE. Mucosal changes beyond the 
duodenum were detected in 18 (66.6%) patients and in 3 (11.1%) patients the whole SB was 
affected. Another newly published study, (Muhammad & Pitchumoni,2008) searching for 
celiac disease in older adults, also showed that duodenal mucosa was normal in appearance 
on CE in 71% of patients, but classic abnormalities of celiac disease were present distally. 
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Overall, CE can detect endoscopic markers of celiac disease. In addition, CE seems to be able to 
recognize the extent of disease and may be a tool for follow-up. CE has a high sensitivity 
(range, 70%-95.2%), specificity (range, 63.6%-100%) and high PPV and NPV (96.5%-100% and 
71.4%-88.9%, respectively)(Biagi et al.,2006;Hopper et al., 2007; Muhammad & Pitchumoni 
2008; Petroniene et al., 2005; Rondonotti et al 2007a. 2007b). When an atrophic pattern is 
detected by CE, the patient has a high probability of having celiac disease (Spada et al., 2008). 
CE has also been reported to be able to demonstrate diseases such as adeno-carcinoma, 
lymphoma or ulcerative jejuno-ileitis, which may complicate the course of celiac disease. A 
limitation is that CE is able to detect Marsh III lesions, which are associated with clear mucosal 
abnormalities, but may not distinguish between Marsh I and II lesions (Spada et al., 2008). At 
present, CE is an alternative to endoscopy with biopsy in patients with suspected celiac 
disease who do not consent to the conventional methods. 
3.4 Small bowel tumors and polyps 
Capsule endoscopy is a major advance in the diagnosis of SB tumors. Before the introduction 
of CE, malignant neoplasms of the SB were often diagnosed at a later stage of the disease, 
mostly during the work-up of obstructive symptoms. Diagnosis is delayed because 
conventional imaging techniques fail to detect small neoplasm’s in almost half of the patients. 
SB tumors are a rare disease, accounting for 1%-3% of all primary GI tumors. SB mass lesions 
are responsible for OGIB in up to 10% of patients. (Ciresi & Scholten, 1995; DiSario et al., 1994; 
Lewis, 1994; Lewis et al., 2005; Kariv & Arber 2003). Early clinical studies of CE have reported 
a frequency of SB tumors ranging between 6% and 9% (Bailey et al.,2006; Cobrin et al.,2006; de 
Franchis et al.,2004; Estevez et al.,2007; Schwartz &Barkin,2007; Urbain et al.,2006). This has led 
to an idea that CE doubled the rate of diagnosing SB tumors. However, a recent multicenter 
European study showed that the frequency of SB tumors was 2.4% and the most common 
indication for CE was OGIB (Pennazio et al., 2008; Rondonotti et al., 2008). SB tumors appear 
as masses or polyps in most patients and ulcer or stenoses in a minority of patients. It is not 
possible to distinguish the type of tumor based only on CE pictures. Most of the tumors reside 
in the mid SB (Rondonotti et al., 2008).Capsule endoscopy is also useful for the surveillance of 
polyps in patients with inherited GI polyposis syndromes (Familial adenomatous polyposis 
and Peutz- Jeghers syndrome), who are at increased risk of developing polyps in the SB. 
Several studies comparing the yield of CE to other imaging modalities in patients with 
polyposis syndromes have shown that CE is accurate in the detection of polyps. The same 
studies also emphasized that the duodenum is a potential blind point of CE because the 
capsule passes quickly with tumble and results in inadequate examination. CE underestimated 
the total number of polyps and did not reliably detect larger polyps in that portion (Wong et 
al., 2006). Nevertheless, more prospective studies with longer follow-up are required, to define 
the role of capsule endoscopy findings in the outcome of patients with gastrointestinal 
polyposis syndrome. 
3.5 Other indications 
Abdominal pain is one of the most common symptoms of patients referred to the 
gastroenterologist. Use of CE for the evaluation of abdominal pain is debated. Although 
some serious causes are identified in such patients, CE is mostly unyielding. If patients with 
other signs and symptoms of inflammation were selected, than the diagnostic yield was 
considerably higher (El-Matary, 2008). Capsule endoscopy may be helpful in the diagnosis 
of the following diseases: surveillance for NSAID side effects, Henoch Schönlein purpura, 
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indeterminate colitis, protein losing enteropathy, intestinal lymphangiectasia,  Meckel’s 
diverticulum, follow-up of SB transplantation, GVHD, and bowel changes in refractory 
pouchitis (El-Matary,2008). 
4. Contra-indication and safety issue of capsule endoscopy 
Capsule endoscopy is a safe and contraindications (Table-2) include the presence of 
intestinal obstruction, fistulas and strictures. Swallowing abnormalities, esophageal 
stricture, pseudo-obstruction, severe motility disorder are other contraindications for the 
procedure. Relative contraindications are pregnancy, numerous diverticuli, Zenker’s 
diverticulum, gastroparesis, and previous pelvic/abdominal surgery.  
 
Absolute
 Bowel obstruction 
 Extensive and active Crohn’s 
 Disease ± strictures 
 Intestinal pseudo-obstruction 
 Young children (<10 years) 
 
Relative 
 Cardiac pacemakers 
 Implanted electro-medical Devices 
 Dysphagia 
 Previous abdominal surgery 
 Pregnancy 
Diverticulosis
Table 2. Contra Indication 
Other former contraindications such as implanted cardiac pacemakers or other electro-
medical devices and patients with swallowing disorders have been excluded since some 
studies showed no interference between capsule endoscopy and pacemaker or implantable 
defibrillators functioning (Leighton et al.,2004,2005) and endoscopic placement of the 
capsule into the gut (Leung & Sung,2004). The retention of the device is the main 
complication  of the procedure and is defined when CE remains in the digestive tract for a 
minimum of 2 wk (Cave et al.,2005).The frequency of this problem varies, depending mostly 
on the clinical indication for CE, and ranges from 0% in  healthy subjects, to 1.5% in patients 
with obscure gastrointestinal bleeding, to 5% in patients with suspected Crohn’s disease 
(Mata et al.,2008) and to 21% in patients with intestinal obstruction(Pennazio,2006).How to 
prevent capsule retention has yet to be defined since neither radiologic studies nor the 
“patency capsule” has shown conclusive results so far. The clinical setting of each patient, as 
well as some features related to intestinal strictures (previous small bowel surgery, NSAIDs, 
suspected small bowel Crohn’s disease), have to be analyzed prior to the study. Patients 
should be informed about the possibility of capsule retention and further treatment. 
5. Technical limitations 
It cannot be used to obtain biopsy specimens or for endoscopic treatment and it cannot be 
controlled remotely (Pennazio,2006). CE has also some clinical limitations which are 
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problems in sizing and locating small bowel lesions(Rondonotti et al.,2008), a possible false-
negative CE result, global miss rate is about 11%, ranging from 0.5% for ulcerative lesions to 
18.9% for neoplastic disease and almost 20% of procedures the capsule does not reach the 
cecum while it is active (Waterman & Eliakim,2009). 
6. Esophageal capsule – PillCam ESO 
The esophageal capsule (PillCamTM ESO) which was approved by the FDA in November 
2004, has a double head with the potential of 14 frames per second. The new-generation 
capsule endoscopy SB2 takes 18 frames per second. The battery life is only  20 minutes. The 
capsule has two cameras, each taking seven frames per second in the first 10 minutes, then 
four frames in the remaining 10 minutes. The patient does not need sedation, there is no 
recovery time, and no intubation or insufflations is used. The two FDA-approved 
indications for the esophageal capsule are screening and follow-up of esophageal varices 
and screening for Barrett’s esophagus in gastro-esophageal reflux patients.  
 
  
Fig. 3. A: PillCam™ ESO image of erosive esophagitis; B: endoscopy image of distal 
esophagus in the same patient. 
 
  
Fig. 4. A: PillCam ESO™ image showing esophageal varices; B: Upper endoscopy image of 
distal esophagus in the same patient. 
According to the guidelines of the American Society of Gastrointestinal Endoscopy, 
established cirrhosis and cholestatic liver disease with a low platelets count are clear 
indications for esophago-gastro-duodenoscopy(EGD)(Qureshi et al.,2005).Large varices 
dictate treatment with propranolol or ligation. Capsule endoscopy may replace EGD for 
diagnosis of varices. Grading of varices according to the capsule endoscopy study is simpler 
than that of EGD.  Three grades were evaluated: C0 = no varices, C1 =small and non-
tortuous varices<25% of the circumference of the frame, and C2 =large varices>25% of the 
frame circumference. A recent multicenter international study with PillCam ESO prior to 
EGD was performed in 97 cirrhotic patients (Eisen,2006).EGD was performed within 48 
A B
A
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hours by endoscopists blinded to the results of capsule endoscopy, while the PillCam ESO 
study was read by a blinded second investigator.Complete agreement was demonstrated in 
84 of the 97 patients. The sensitivity and specificity of the capsule endoscopy for esophageal 
varices were 86.6% and 86.7%, respectively. A recent study (Galmiche et al.,2008) 
demonstrated 79% sensitivity and 94% specificity of capsule endoscopy for Barrett’s 
esophagus in 77 patients. However, these results could not be demonstrated in another 
recent paper and there was a significant variation between observers. 
7. Colonic capsule – PillCam colon 
The colonic capsule was ready for research in 2006 and had been studied by Israeli, 
American and European groups of investigators  (Eliakim et al.,2006; Fireman & Kopelman, 
2007). The capsule had great potential for colorectal cancer screening since the procedure is 
not invasive. The first generation of the colonic capsule had two cameras on both heads, 
taking four frames per second. It is 5 mm longer than the small bowel capsule. The main 
limitation of this examination is the colonic preparation before the procedure as the colon 
must be perfectly clean without any remnants of stool. Sedation is not needed, and 
radiation, intubation and insufflation are not involved. The capsule procedure may become 
the first-line examination of the colon. It can be performed instead of colonoscopy when there 
is a contraindication to colonoscopy, is suitable for people unwilling to undergo colonoscopy 
or complete failed colonoscopy, and it can be used for screening colitis patients. It is believed 
that compliance for capsule endoscopy as a screening tool will be higher than for colonoscopy.  
 
   
   
Fig. 5. Images captured by the Pillcam™ Colon and conventional colonoscopy. A and B: 
Pedunculated polyp in the sigmoid colon; C and D: Ulcerated tumor in the transverse colon; 
E and F: Flat adenoma in the ascending colon. 
In a recently published European multicenter study of 328 patients (Von Gossum et 
al.,2009), the sensitivity and specificity of capsule endoscopy for detecting polyps ≤ 6 mm in 
size were 64% (95% confidence interval 59–72) and 84% (95% CI 81–87), respectively, and for 
detecting advanced adenoma sensitivity and specificity were 73% (95% CI 61–83) and 79% 
A C E
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(95% CI 77–81) respectively of 19 cancers detected by colonoscopy, 14 were detected by 
capsule endoscopy (sensitivity 74%, 95% CI 52–88). For all lesions, the sensitivity of capsule 
endoscopy was higher in patients with good or excellent colon cleanliness compared to 
those with fair or poor colon cleanliness. 
8. Next generation capsule endoscopy 
What, would be the ideal capsule of the gastroenterologist’s Wildest imagination? Would 
we prefer a single capsule that, in one ‘‘shot’’, can give us the entire view from the oral 
cavity to the anal canal, or are we hoping that someday there will be an “intelligent” capsule 
that specializes in each section of the GI tract? Unfortunately, the anatomical and 
physiological differences in the GI tract make it impossible to use the same capsule for both 
purposes. Small bowel, esophageal and colonoscopy capsules are now commercially 
available. The latter two are equipped with miniature cameras on both ends of two video 
cameras. How we would love to be able to pinpoint drug deliveries in specific diseases such 
as Crohn’s disease! The problem is that it would have to be done daily over a long period 
and this would be time consuming and costly. A pre-programmed non-viewing (i.e. no 
camera) capsule for drug delivery would be much cheaper and one can imagine a 
combination of viewing and non-viewing capsules that can be used to make this treatment 
efficient and cost effective. For clinicians, the capsule’s motility feature in the small bowel 
would open a window to study the patho-physiology of relatively elusive medical entities 
such as irritable bowel syndrome. Malagelada et al., 2008 were the first to publish their 
findings on CE motility in the clinical setting and they found that CE was useful in 
diagnosing patients with irritable bowel syndrome. Next in our dream of CE are zooming or 
magnification capabilities. Why not? Think of chromo-endoscopy, narrow band imaging, 
ultrasound imaging and the delivering of therapy including tissue coagulation and 
immunologically or chemically targeted optical recognition of malignancy as it exists in 
endoscopy, capable of spraying fluid (methylene blue, Lugol solution, etc.) in specific areas 
of the small bowel. At present, the capsule cannot obtain biopsies, aspirate fluid or brush 
lesions for cytology. These techniques require real-time viewing as well as radio-controlled 
triggering and remote controlled capsule manipulation if they are to be used with precision. 
However, optical biopsy seems feasible (DaCosta et al.,2005).We can easily visualize our 
capsule eventually becoming  a complete miniature laboratory with the functions of bio-
sensing luminal contents and biopsy (probably by optical technologies) as well. 
The quality of current CE images is inferior to that of conventional endoscopes and the 
solution awaits advances in microelectronics that will lead to image sensors with a smaller 
pixel size that enable higher resolution. In addition, current CE systems use image data 
compression which causes blurring at the edges of objects and leads to lower image quality, a 
major limitation of CE. In particular, depletion of the two silver oxide batteries used in current 
devices may prevent complete imaging of the small intestine if the pill remains in the stomach 
for too long. The problem becomes most apparent by the inability to view the cecum (the 
marker of a complete examination) in 10%-15% of CE examinations of the small bowel(Neu et 
al.,2005;Triester et al.,2006).This will eventually be overcome by using power transfer methods 
from outside the body. In the short term, this problem can partly be solved by using more 
efficient power management algorithms that enable an 11 h recording time. There have been 
important “breakthroughs” in battery design with the advent of carbon nanotubes 
(Buckytubes) which have the intrinsic characteristics desired in the material used as electrodes 
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in batteries and capacitors. Other methods that are under consideration for development for 
solving imaging issues include control units that vary the frame rate. One example is the 
OMOM capsule, developed at Chongqing Jinshan Science and Technology Group (Chongqing, 
China), which can switch from 0.5 frames per second (fps) inside the stomach to 2 fps after 
entering the pylorus (DaCosta et al.,2005).In a well-conducted randomized prospective study 
of 50 patients in China, the cecum was visualized in the 25 subjects who ingested the capsule 
in the switching frame rate mode compared with 18 of 25 in whom the pill functioned at a 
steady frame rate of 2 fps (Moglia et al.,2008). The benefit from size reduction and power 
efficiency is best exemplified by MiroCam by Intromedic (Seoul, South Korea). This is the first 
endoscopic capsule that uses the human body instead of radiofrequency to transmit data, 
reducing power consumption. In the first clinical trial on 45 patients in South Korea, MiroCam 
captured images from the whole small intestine as far as the cecum in all the subjects. Because 
the device does not use image compression, the bowel mucosa was viewed without blurring 
or distortion in over 90% of patients(de Franchis et al.,2005)This system also uses fewer 
components for remote transmission, thus saving space for the possible addition of modules 
for biopsy or locomotive guidance (Liao et al.,2009). 
We eagerly look forward to the day that we will be able to ‘‘control and steer’’ the CE as 
endoscopists are able to do in standard endoscopy. Two research projects supported by the 
European Union are currently pursuing this goal. One is VECTOR (Versatile Endoscopic 
Capsule for gastrointestinal Tumor Recognition and therapy) and the other is NEMO (Nano-
based capsule-Endoscopy with Molecular Imaging and Optical biopsy). The former aims to 
develop a self-propelled miniaturized robotic pill for advanced diagnostics and treatment in 
the digestive tract. Over the last few months, the topic of the feasibility and effectiveness of the 
combined use of external static magnetic fields to achieve wirelessly controllable and precise 
camera steering has been published(Gao et al.,2010;Swain et al.,2010;Valdastri et al.,2010)The 
second study is looking into the detection of surface and deep seated pathology by photonic 
technologies that enable optical biopsies. This would eliminate the need to take biopsy 
specimens and perform histological examination (Swain, 2008). 
9. Conclusion  
Capsule endoscopy is the latest evolution in gastrointestinal endoscopy and the first to 
enable complete investigation of the small bowel. It is a simple and well-tolerated 
procedure. Capsule retention is the major complication. Care must be taken in patients with 
symptoms suggesting partial obstruction and CD. SB series and computerized tomography 
enteroclysis before CE may reveal stenosis. The newly developed patency capsule may be an 
alternative for detection of stenoses. The value of CE in patients with OGIB appears to be 
high and is supported by high yields in the literature. CD and celiac disease appear to be 
areas where use of CE would be helpful. There may also be an indication for CE in CD 
surveillance and follow-up. The diagnostic role of CE extends beyond the SB. Recent new 
developments in the field of capsule endoscopy include the esophageal capsule (PillCam 
ESO™) and the colonic capsule (PillCam Colon™). More research is needed to explore the 
feasibility of CE in these contexts. Blind spots of CE such as the duodenum should be 
examined by a second look endoscopy before the CE procedure, especially in patients with 
OGIB. After negative endoscopic examinations, CE should be recommended as a first-line 
investigation over balloon assisted enteroscopies in view of its noninvasiveness, higher 
probability of visualizing the entire small intestine and the similar diagnostic yield of both 
www.intechopen.com
 
New Techniques in Gastrointestinal Endoscopy 
 
96
investigations. Such an approach may decrease the time between diagnosis and 
intervention. A second look CE may reveal more findings in up to 35% of patients who had 
prior non diagnostic CE. 
The ideal next generation CE of the gastroenterologist’s imagination should be capable of 
performing an ordinary biopsy as well as carry out an online analysis (an “optical” biopsy) 
and ‘‘stop’’ bleeding by an adrenaline injection, a heat probe, argon plasma coagulation, etc. 
The ultimate capsule would include special detectors for white blood cells and be capable of 
checking oncological markers (e.g. CEA, CA 19-9), perform serology tests (e.g. anti-
endomysial, IgE) and measure various cytokines, pH, temperature and pressure, in addition 
to delivering drugs. The capsule’s motility feature in the small bowel may open a window to 
study the patho-physiology of relatively elusive medical entities such as irritable bowel 
syndrome (Fireman & Kopelman, 2007; Fireman et al, 2004; Nakamura & Terano, 2008; 
Kochman & Swain, 2007; Swain, 2008). Finally, the optimal capsule needs to contain a 
computerized system for automatic detection of pathologies such as the design of a holter 
electrocardiographic recording in order to overcome the drawback of time-consuming 
viewing the video. Future gastroenterologists will have a number of types of capsules from 
which to choose according to whether the purpose of the evaluation is diagnostic and/or 
therapeutic. 
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